Experts: COVID-19 Vaccine Won’t be Ready by November
Coalition members also say that Americans should receive the flu vaccine as soon as possible, according to the graphic.
Don’t expect a vaccine for coronavirus disease 2019 (COVID-19) to show up on November 1 this year, say healthcare experts. The MJH Life Sciences COVID-19 Coalition does not believe that a COVID-19 vaccine will be released by then, while identifying engagement and uptake as the top challenge to the US Department of Health and Human Services vaccine distribution strategy. Coalition members also say that Americans should receive the flu vaccine as soon as possible, according to the graphic.
The Coalition is a partnership with 10 nationally recognized experts in infectious disease, public health, epidemiology, and virology, who work to generate the most accurate, up-to-the-minute information on the pandemic’s ever-evolving impact on health care professionals and the patients they treat through live, webinar events every two weeks, white papers, and surveys.
The next COVID-19 event, "Navigating the COVID-19 Treatment Landscape," will be held October 13, 2020, at 6PM ET. Register here.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
